Multiple myeloma, a treatable but incurable blood cancer, is rising sharply in India, especially among those over 60. Dr.

The good news, I guess, is that we have very many different treatment options for relapse refractory multiple myeloma, and some of that is considered in the background of what we do for patients with ...

Formal communication could help ease the transition of care from specialized myeloma centers to community clinic, according ...

New CAR T-cell therapy shows remarkable efficacy in treating relapsed multiple myeloma, achieving high response rates and ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

In this exclusive MedPage Today video, investigator Shahzad Raza, MD, of the Cleveland Clinic Cancer Institute, explains why ...

Drugs that treat a similar plasma cell disease, multiple myeloma, can sometimes be effective in people with AL amyloidosis. By far, the most important of these drugs is daratumumab (Darzalex), a ...

Background: Amyloidosis, particularly light-chain (AL) amyloidosis, is a rare but serious complication of multiple myeloma (MM) that can significantly impact cardiac function, particularly among ...

"We want to cure multiple myeloma, one way or another," S. Vincent Rajkumar, MD, chair of the Myeloma Amyloidosis Dysproteinemia Group at Mayo Clinic in Rochester, Minnesota, told MedPage Today ...

The two conditions that AL amyloidosis can overlap with is most commonly MGAS, or a monoclonal gammopathy, and then less commonly, but more severe, would be multiple myeloma.

Ríos-Tamayo R, Krsnik I, Gómez-Bueno M, et al. AL amyloidosis and multiple myeloma: A complex scenario in which cardiac involvement remains the key prognostic factor. Life (Basel) . 2023;13(7):1518.

Multiple myeloma and AL amyloidosis link to plasma cells in the bone marrow. The conditions co-occur in 10–15% of people with MM. Read about the connection.